Beyond respiratory infections, other common clinical manifestations in humans with CARMIL2 deficiencies include dermal disease, failure to thrive, other recurrent infections, allergic symptoms, chronic diarrhea, Epstein–Barr virus-related leiomyomas, mucocutaneous candidiasis, skin abscesses, and respiratory allergies [31]. Here, CARMIL2 is linked to respiratory tract infectious disorder.